Which funding models to accelerate anti-parasitic and anti-infectious innovation?

Which funding models to accelerate anti-parasitic and anti-infectious innovation?

Which funding to support new vaccines, drugs and treatment strategies in Africa? What is the role of philanthropic funding? How can foundations and governments form alliances to fund better R&D?

Isaac Haq

Analyst
France
ArchiMed Group

Julie Brady

Business Development Manager
United Kingdom
Drug Discovery Unit

Santiago Ini

Director of Business Development
Israel
T3-Technion Technology Transfer

Yann Ferrisse

Business Development, Head
Switzerland
Global Antibiotic Research & Development Partnership
  • No products in the cart.